| View |
|
DRP-14771
|
Sitagliptin (as phosphate monohydrate)
|
None
|
25 mg
|
Film-Coated Tablet
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
Initial
|
02 January 2024
|
02 January 2029
|
| View |
|
DR-XY48970
|
Miconazole
|
Iconagel
|
20mg/g (2% w/w)
|
Oral Gel
|
-
|
The IBN SINA Pharmaceutical Industry Ltd.
|
Bangladesh
|
Initial
|
02 January 2024
|
02 January 2029
|
| View |
|
DRP-14772
|
Ampicillin (as sodium)
|
Ampistar 250
|
250 mg
|
Powder for Injection (I.V./I.M.)
|
-
|
Inject Care Parenterals Pvt. Ltd.
|
India
|
Initial
|
02 January 2024
|
02 January 2029
|
| View |
|
DRP-8535-02
|
Olanzapine
|
Lanspro-10
|
10 mg
|
Orally Disintegrating Tablet
|
Antipsychotic
|
Stallion Laboratories Pvt. Ltd.
|
India
|
Renewal
|
20 March 2024
|
31 October 2029
|
| View |
|
BRP-014-02
|
Insulin Glargine
|
None
|
100 Units (equivalent to 3.64 mg)/mL
|
Solution for Injection (SC)
|
Antidiabetics
|
Sanofi-Aventis Deutschland GmbH
|
Germany
|
CLIDP Conversion
|
09 January 2024
|
26 February 2028
|
| View |
|
DRP-10246-08
|
Ceftriaxone (as sodium)
|
Ceftravin
|
1 g
|
Powder for Injection (IM/IV)
|
Antibacterial (Third-Generation Cephalosporin)
|
Theon Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
10 January 2024
|
01 October 2026
|
| View |
|
DRP-10721-02
|
Dapagliflozin
|
None
|
10 mg
|
Film-Coated Tablet
|
Blood Glucose Lowering Drug [Sodium-glucose co-transporter 2 (SGLT2) Inhibitor]
|
Lloyd Laboratories, Inc
|
Philippines
|
CLIDP Conversion
|
09 January 2024
|
11 November 2026
|
| View |
|
DRP-11044-05
|
Potassium Citrate
|
Azentrate
|
1080 mg
|
Extended-Release Tablet
|
Antiurolithic
|
Magbro Healthcare Pvt. Ltd.
|
India
|
CLIDP Conversion
|
08 January 2024
|
18 January 2027
|
| View |
|
DRP-11789-04
|
Dapagliflozin
|
Dhafag-Ten
|
10 mg
|
Film-Coated Tablet
|
Blood Glucose Lowering Drug (SGLT2 Inhibitor)
|
Sapphire Lifesciences Pvt. Ltd.
|
India
|
CLIDP Conversion
|
08 January 2024
|
29 April 2027
|
| View |
|
DRP-12554-02
|
Omeprazole (as sodium)
|
Omeptam
|
40 mg
|
Powder for Injection (I.V.)
|
Proton Pump Inhibitor
|
Reyoung Pharmaceutical Co. Ltd.
|
China
|
CLIDP Conversion
|
09 January 2024
|
01 September 2027
|
| View |
|
DRP-13475-03
|
Ipratropium bromide + Salbutamol (as sulfate)
|
Broncovent Plus
|
500 mcg/ 2.5 mg
|
Solution for Inhalation
|
Adrenergic in combination with anticholinergic
|
Legency Remedies Pvt. Ltd
|
India
|
CLIDP Conversion
|
08 January 2024
|
27 February 2028
|
| View |
|
DRP-13799-02
|
Atracurium Besilate
|
Atracare-Star
|
10 mg/mL
|
Solution for Injection (IV)
|
Muscle Relaxant
|
Farbe Firma Pvt. Ltd.
|
India
|
CLIDP Conversion
|
08 January 2024
|
05 May 2028
|
| View |
|
DRP-13872-01
|
Salbutamol (as sulfate)
|
Ventam
|
2 mg/5 mL
|
Syrup
|
Selective beta-2-adrenoreceptor agonist
|
Enicar Pharmaceuticals Pvt. Ltd
|
India
|
CLIDP Conversion
|
08 January 2024
|
09 May 2028
|
| View |
|
DRP-13888-04
|
Iron (as Iron Sucrose)
|
Isufer
|
20 mg/mL (100 mg/5 mL)
|
Solution for Injection (IV)
|
Antianemic
|
Makcur Laboratories Limited
|
India
|
CLIDP Conversion
|
08 January 2024
|
11 May 2028
|
| View |
|
DRP-13983-01
|
Apixaban
|
None
|
5 mg
|
Film-Coated Tablet
|
Antithrombotic agent (Direct factor Xa inhibitor)
|
Stallion Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
27 February 2024
|
31 May 2028
|
| View |
|
DRP-13984-01
|
Apixaban
|
Appixvan
|
2.5 mg
|
Film-Coated Tablet
|
Antithrombotic agent (Direct factor Xa inhibitor)
|
Stallion Laboratories Pvt. Ltd
|
India
|
CLIDP Conversion
|
08 January 2024
|
31 May 2028
|
| View |
|
DRP-14042-01
|
Paracetamol + Tramadol Hydrochloride
|
None
|
325 mg/37.5 mg
|
Tablet
|
Analgesic/ Antipyretic/ Opioid Analgesic
|
Medico Remedies Limited
|
India
|
CLIDP Conversion
|
08 January 2024
|
08 June 2025
|
| View |
|
DRP-14440-02
|
Dabigatran Etexilate (as mesilate)
|
Dabbtrann-150
|
150 mg
|
Capsule
|
Direct Thrombin Inhibitor
|
Stallion Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
10 January 2024
|
05 September 2028
|
| View |
|
DRP-14441-01
|
Dabigatran Etexilate (as mesilate)
|
Dabbtrann-110
|
110 mg
|
Capsule
|
Direct Thrombin Inhibitor
|
Stallion Laboratories Pvt. Ltd
|
India
|
CLIDP Conversion
|
10 January 2024
|
05 September 2028
|
| View |
|
DRP-14441-02
|
Dabigatran Etexilate (as mesilate)
|
Amgathran-110
|
110 mg
|
Capsule
|
Direct Thrombin Inhibitor
|
Stallion Laboratories Pvt. Ltd
|
India
|
CLIDP Conversion
|
10 January 2024
|
05 September 2028
|